OR1A2: A Potential Drug Target for Various Diseases (G26189)
OR1A2: A Potential Drug Target for Various Diseases
OR1A2 (MGC119930) is a protein that is expressed in various tissues throughout the body, including the brain, heart, kidneys, and gastrointestinal tract. It is a member of the OR1A2 family, which includes several similar proteins that are involved in various cellular processes, including cell signaling, migration, and invasion.
One of the unique features of OR1A2 is its ability to interact with several different signaling pathways, including the TGF-β pathway, the PI3K/Akt pathway, and the NF-kappa-B pathway. This makes OR1A2 a potentially interesting drug target for a variety of diseases.
OR1A2 has been shown to be involved in several different diseases and conditions, including cancer, neurodegenerative diseases, and autoimmune disorders. For example, studies have shown that OR1A2 is often overexpressed in various types of cancer, including breast, ovarian, and prostate cancer. This suggests that targeting OR1A2 may be a promising strategy for the development of new treatments for these diseases.
In addition to its involvement in cancer, OR1A2 has also been shown to be involved in several other biological processes that are important for human health. For example, OR1A2 has been shown to play a role in the regulation of cell migration and the development of neurodegenerative diseases. This suggests that targeting OR1A2 in these contexts may be a promising strategy for the development of new treatments for a variety of conditions.
Despite the potential benefits of targeting OR1A2, there are also several potential drawbacks to consider. For example, OR1A2 is a protein that is expressed in many different tissues throughout the body, which could make it difficult to effectively target it. Additionally, the precise mechanism by which OR1A2 functions in the body is not well understood, which could make it difficult to develop effective treatments.
Despite these challenges, the potential targeting of OR1A2 makes it an important area of research for the development of new treatments for a variety of diseases. Further studies are needed to better understand the role of OR1A2 in different biological processes and to develop effective treatments.
Protein Name: Olfactory Receptor Family 1 Subfamily A Member 2
Functions: Odorant receptor
The "OR1A2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about OR1A2 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
OR1B1 | OR1C1 | OR1D2 | OR1D4 | OR1D5 | OR1E1 | OR1E2 | OR1E3 | OR1F1 | OR1F2P | OR1G1 | OR1I1 | OR1J1 | OR1J2 | OR1J4 | OR1K1 | OR1L1 | OR1L3 | OR1L4 | OR1L6 | OR1L8 | OR1M1 | OR1N1 | OR1N2 | OR1P1 | OR1Q1 | OR1S1 | OR1S2 | OR2A1 | OR2A1-AS1 | OR2A12 | OR2A14 | OR2A2 | OR2A20P | OR2A25 | OR2A4 | OR2A42 | OR2A7 | OR2A9P | OR2AE1 | OR2AG1 | OR2AG2 | OR2AJ1 | OR2AK2 | OR2AL1P | OR2AM1P | OR2AP1 | OR2AT4 | OR2B11 | OR2B2 | OR2B3 | OR2B6 | OR2C1 | OR2C3 | OR2D2 | OR2D3 | OR2F1 | OR2F2 | OR2G2 | OR2G3 | OR2G6 | OR2H1 | OR2H2 | OR2I1P | OR2J1 | OR2J2 | OR2J3 | OR2J4P | OR2K2 | OR2L13 | OR2L1P | OR2L2 | OR2L3 | OR2L5 | OR2L8 | OR2L9P | OR2M1P | OR2M2 | OR2M3 | OR2M4 | OR2M5 | OR2M7 | OR2Q1P | OR2S2 | OR2T1 | OR2T10 | OR2T11 | OR2T12 | OR2T2 | OR2T27 | OR2T29 | OR2T3 | OR2T33 | OR2T34 | OR2T35 | OR2T4 | OR2T5 | OR2T6 | OR2T7 | OR2T8
